id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0297-0003,FDA,FDA-2005-N-0297,Supporting Statement,Supporting & Related Material,Background Material,2006-06-23T04:00:00Z,2006,6,,,2025-07-15T22:44:45Z,,0,0,0900006480446da8
FDA-2005-N-0297-0004,FDA,FDA-2005-N-0297,Supporting Statement,Supporting & Related Material,Background Material,2006-06-23T04:00:00Z,2006,6,,,2025-07-15T22:45:48Z,,0,0,0900006480446da9
FDA-2005-N-0297-0005,FDA,FDA-2005-N-0297,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Substances Generally Recognized as Safe: Notification Procedure,Notice,Notice of Approval,2006-06-23T04:00:00Z,2006,6,2006-06-21T04:00:00Z,,2025-10-16T22:34:28Z,E6-9827,0,0,0900006480446daa
FDA-2005-N-0297-0002,FDA,FDA-2005-N-0297,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Substances Generally Recognized as Safe: Notification Procedure,Notice,30 Day Proposed Information Collection,2006-04-18T04:00:00Z,2006,4,2006-04-06T04:00:00Z,,2025-10-16T22:32:28Z,E6-5088,0,0,0900006480446da7